World's top Biotechnology & Medical Research stocks
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
BHVNBiohaven | $3.42bn | n/a | n/a |
RAREUltragenyx Pharmaceutical | $3.37bn | n/a | n/a |
SYNGENESyngene International | IN₹278.68bn | 53.76 | 0.18% |
TLXTelix Pharmaceuticals | AU$4.98bn | 869 | n/a |
SWTXSpringWorks Therapeutics | $3.18bn | n/a | n/a |
1548Genscript Biotech | HK$24.64bn | n/a | n/a |
ARWRArrowhead Pharmaceuticals | $3.11bn | n/a | n/a |
IDYAIdeaya Biosciences | $3.10bn | n/a | n/a |
SMMTSummit Therapeutics | $3.08bn | n/a | n/a |
PTCTPTC Therapeutics | $2.98bn | n/a | n/a |
XENEXenon Pharmaceuticals | $2.94bn | n/a | n/a |
FOLDAmicus Therapeutics | $2.94bn | n/a | n/a |
KDNYChinook Therapeutics | $2.90bn | n/a | n/a |
IOVAIovance Biotherapeutics | $2.89bn | n/a | n/a |
GHGuardant Health | $2.88bn | n/a | n/a |
APGEApogee Therapeutics | $2.88bn | n/a | n/a |
DYNDyne Therapeutics | $2.85bn | n/a | n/a |
ACLXArcellx | $2.85bn | n/a | n/a |
DNLIDenali Therapeutics | $2.85bn | n/a | n/a |
MORMorphosys AG | €2.58bn | n/a | n/a |